PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 106 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 3.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,246,554 | -25.4% | 473,975 | +0.2% | 0.20% | -11.3% |
| Q2 2023 | $1,669,937 | +14.2% | 473,070 | 0.0% | 0.23% | +21.7% |
| Q1 2023 | $1,461,786 | -38.5% | 473,070 | -15.8% | 0.19% | -48.1% |
| Q4 2022 | $2,375,606 | +79.0% | 561,609 | +0.3% | 0.36% | +30.0% |
| Q3 2022 | $1,327,000 | -19.7% | 559,769 | -3.5% | 0.28% | -33.6% |
| Q2 2022 | $1,653,000 | -12.2% | 579,915 | -11.3% | 0.42% | -30.8% |
| Q1 2022 | $1,882,000 | -9.4% | 653,445 | -4.4% | 0.61% | -45.1% |
| Q4 2021 | $2,078,000 | – | 683,619 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $4,713,260 | 4.15% |
| Eversept Partners, LP | 1,681,149 | $4,421,422 | 0.37% |
| Camber Capital Management LP | 4,235,000 | $11,138 | 0.37% |
| Kynam Capital Management, LP | 473,975 | $1,246,554 | 0.20% |
| GLOBEFLEX CAPITAL L P | 538,559 | $1,416,410 | 0.17% |
| Affinity Asset Advisors, LLC | 202,349 | $532,178 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 279,629 | $735 | 0.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 363,666 | $956,442 | 0.06% |
| Patriot Financial Group Insurance Agency, LLC | 67,000 | $176,210 | 0.04% |
| ACADIAN ASSET MANAGEMENT LLC | 1,858,000 | $4,884 | 0.02% |